Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences Market Cap : 54.03M for April 17, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Apellis Pharmaceuticals, Inc. | 5.228B |
| ACADIA Pharmaceuticals, Inc. | 3.780B |
| Alnylam Pharmaceuticals, Inc. | 41.07B |
| Savara, Inc. | 1.183B |
| BioMarin Pharmaceutical, Inc. | 10.51B |
Market Cap Related Metrics
| Price to Book Value | 0.7711 |
| Price | 7.33 |
| Earnings Yield | -104.5% |